BioStem Technologies, Inc. (OTCMKTS:BSEM) Sees Significant Increase in Short Interest

BioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report) was the recipient of a large growth in short interest in March. As of March 31st, there was short interest totalling 170,200 shares, a growth of 20.5% from the March 15th total of 141,300 shares. Based on an average daily trading volume, of 85,600 shares, the short-interest ratio is currently 2.0 days. Currently, 1.0% of the shares of the stock are sold short.

BioStem Technologies Trading Up 1.1 %

OTCMKTS:BSEM traded up $0.16 during trading hours on Friday, reaching $14.69. 74,537 shares of the company were exchanged, compared to its average volume of 67,789. The stock's 50-day moving average is $11.04 and its 200-day moving average is $13.83. BioStem Technologies has a twelve month low of $6.77 and a twelve month high of $28.26. The firm has a market cap of $245.40 million, a PE ratio of 21.61 and a beta of 0.09.

BioStem Technologies Company Profile

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.